Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 22935421)

1.

Genetic analysis of the SIRT1 gene promoter in myocardial infarction.

Cui Y, Wang H, Chen H, Pang S, Wang L, Liu D, Yan B.

Biochem Biophys Res Commun. 2012 Sep 21;426(2):232-6. doi: 10.1016/j.bbrc.2012.08.071. Epub 2012 Aug 21.

PMID:
22935421
2.

Genetic analysis of the SIRT1 gene promoter in ventricular septal defects.

Shan J, Pang S, Wanyan H, Xie W, Qin X, Yan B.

Biochem Biophys Res Commun. 2012 Sep 7;425(4):741-5. doi: 10.1016/j.bbrc.2012.07.145. Epub 2012 Aug 3.

PMID:
22885181
3.

Genetic analysis of SIRT1 gene promoter in sporadic Parkinson's disease.

Zhang A, Wang H, Qin X, Pang S, Yan B.

Biochem Biophys Res Commun. 2012 Jun 15;422(4):693-6. doi: 10.1016/j.bbrc.2012.05.059. Epub 2012 May 18.

PMID:
22613205
4.

Functional sequence variants within the SIRT1 gene promoter in indirect inguinal hernia.

Han Q, Zhang Y, Li W, Fan H, Xing Q, Pang S, Yan B.

Gene. 2014 Aug 1;546(1):1-5. doi: 10.1016/j.gene.2014.05.058. Epub 2014 May 27.

PMID:
24875419
5.

Lack of association between endothelin-1 gene variants and myocardial infarction.

Palacín M, Rodriguez-Pascual F, Reguero JR, Rodríguez I, Avanzas P, Lozano I, Morís C, Alvarez V, Cannata-Andía JB, Lamas S, García-Castro M, Coto E.

J Atheroscler Thromb. 2009 Aug;16(4):388-95. Epub 2009 Aug 11.

6.

Genetic analysis of the TBX3 gene promoter in ventricular septal defects.

Chen D, Qiao Y, Meng H, Pang S, Huang W, Zhang H, Yan B.

Gene. 2013 Jan 10;512(2):185-8. doi: 10.1016/j.gene.2012.10.066. Epub 2012 Oct 29.

PMID:
23116943
7.

Genetic analysis of the ATG7 gene promoter in sporadic Parkinson's disease.

Chen D, Pang S, Feng X, Huang W, Hawley RG, Yan B.

Neurosci Lett. 2013 Feb 8;534:193-8. doi: 10.1016/j.neulet.2012.12.039. Epub 2013 Jan 4.

PMID:
23295909
8.

Genetic analysis of the LAMP-2 gene promoter in patients with sporadic Parkinson's disease.

Pang S, Chen D, Zhang A, Qin X, Yan B.

Neurosci Lett. 2012 Sep 20;526(1):63-7. doi: 10.1016/j.neulet.2012.07.044. Epub 2012 Aug 4.

PMID:
22867958
9.

Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction.

Pearce E, Tregouet DA, Samnegård A, Morgan AR, Cox C, Hamsten A, Eriksson P, Ye S.

Circ Res. 2005 Nov 11;97(10):1070-6. Epub 2005 Oct 6.

10.

Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction.

Koch W, Kastrati A, Böttiger C, Mehilli J, von Beckerath N, Schömig A.

Atherosclerosis. 2001 Nov;159(1):137-44.

PMID:
11689215
11.

Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.

Baessler A, Fischer M, Mayer B, Koehler M, Wiedmann S, Stark K, Doering A, Erdmann J, Riegger G, Schunkert H, Kwitek AE, Hengstenberg C.

Hum Mol Genet. 2007 Apr 15;16(8):887-99. Epub 2007 Feb 26.

12.

Age of onset of myocardial infarction: is promoter polymorphism of the RAGE gene implicated?

Boiocchi C, Bozzini S, Buzzi MP, Schirinzi S, Zorzetto M, Pelissero G, Cuccia M, Falcone C.

Rejuvenation Res. 2011 Feb;14(1):67-73. doi: 10.1089/rej.2010.1091. Epub 2011 Jan 5.

PMID:
21208063
13.

C(-260)T polymorphism in the promoter of CD 14 gene is not associated with myocardial infarction in the Tunisian population.

Sediri Y, Hammami S, Kallel A, Mourali MS, Feki M, Elasmi M, Haj-Taieb S, Omar S, Sanhaji H, Mechmeche R, Jemaa R, Kaabachi N.

Exp Mol Pathol. 2011 Jun;90(3):276-9. doi: 10.1016/j.yexmp.2011.02.004. Epub 2011 Feb 17.

PMID:
21333644
14.

A novel and functional variant within the ATG5 gene promoter in sporadic Parkinson's disease.

Chen D, Zhu C, Wang X, Feng X, Pang S, Huang W, Hawley RG, Yan B.

Neurosci Lett. 2013 Mar 22;538:49-53. doi: 10.1016/j.neulet.2013.01.044. Epub 2013 Feb 4.

PMID:
23384565
15.

Characterization of polymorphic structure of cathepsin G gene: role in cardiovascular and cerebrovascular diseases.

Herrmann SM, Funke-Kaiser H, Schmidt-Petersen K, Nicaud V, Gautier-Bertrand M, Evans A, Kee F, Arveiler D, Morrison C, Orzechowski HD, Elbaz A, Amarenco P, Cambien F, Paul M.

Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1538-43.

16.

Neutrophil elastase gene variation and coronary heart disease.

Schönfelder J, Telgmann R, Nicaud V, Brand E, Dördelmann C, Rüssmann C, Beining K, Schmidt-Petersen K, Evans A, Kee F, Morrison C, Arveiler D, Cambien F, Paul M, Brand-Herrmann SM.

Pharmacogenet Genomics. 2007 Aug;17(8):629-37.

PMID:
17622939
17.

Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction.

Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S.

J Am Coll Cardiol. 2003 Jun 18;41(12):2130-7.

PMID:
12821236
18.

CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.

Haberbosch W, Unkelbach K, Schuster D, Gardemann A, Tillmanns H, Hölschermann H.

Thorac Cardiovasc Surg. 2009 Oct;57(7):386-90. doi: 10.1055/s-0029-1185876. Epub 2009 Sep 30.

PMID:
19795323
19.

An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.

Ashokkumar M, Anbarasan C, Saibabu R, Kuram S, Raman SC, Cherian KM.

Thromb Res. 2011 Oct;128(4):e49-53. doi: 10.1016/j.thromres.2011.05.026. Epub 2011 Jul 16.

PMID:
21762961
20.

A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile.

Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W.

Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):932-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk